ULVR.L - Unilever PLC

LSE - LSE Delayed Price. Currency in GBp
4,270.50
+21.00 (+0.49%)
As of 12:48PM GMT. Market open.
Stock chart is not supported by your current browser
Previous Close4,249.50
Open4,255.00
Bid4,270.00 x 7700
Ask4,271.50 x 40000
Day's Range4,236.50 - 4,288.50
52 Week Range3,678.50 - 4,503.50
Volume792,835
Avg. Volume3,361,341
Market Cap111.61B
Beta (3Y Monthly)0.79
PE Ratio (TTM)16.90
EPS (TTM)252.70
Earnings DateFeb 1, 2019 - Feb 8, 2019
Forward Dividend & Yield1.36 (3.20%)
Ex-Dividend Date2018-11-01
1y Target Est44.57
  • Reuters5 hours ago

    Royal London chairman Pennant-Rea to step down

    The company declined to give any details on why Pennant-Rea, a former Deputy Governor of the Bank of England, was leaving. Sky News had reported https://bit.ly/2PwAQqr on Monday that Parry would be named to succeed Pennant-Rea, who has been chairman since 2013. "Rupert will be getting more involved with small companies and various charities.

  • Financial Times9 hours ago

    [$$] Unilever’s Paul Polman was a standout CEO of the past decade

    “True leadership is putting yourself to the service of others and, if you can marry that with a very noble cause, to make this a better place for all.” That was Paul Polman speaking in a recent Financial ...

  • Reuters4 days ago

    Dutch government proposes law to delay hostile takeovers

    AMSTERDAM (Reuters) - The Dutch cabinet said on Friday it has finished drafting a law granting listed companies the right to call a 250-day grace period to consider a hostile takeover offer. The government ...

  • Financial Times4 days ago

    [$$] GSK’s doses of corporate action this week bring no cure

    Is there another big UK company that has been half as disappointing as GlaxoSmithKline ? A business that once led the world in finding and developing pharmaceuticals is today reduced to expensive purchases ...

  • The Wall Street Journal5 days ago

    [$$] Unilever CMO Keith Weed to Leave Company After 35 Years

    will retire from the company in May, the consumer-products giant said Thursday. Mr. Weed, 57 years old, has been at Unilever for 35 years. . The company, along with its rivals, faces many challenges, including a shift in consumer tastes.

  • Reuters5 days ago

    Unilever Chief Marketing Officer Weed to retire

    The chief marketing officer of Unilever (ULVR.L)(UNc.AS) has decided to retire next year, handing incoming CEO Alan Jope his first big hiring decision. CMO Keith Weed, who oversees the marketing strategy of the world's second-biggest advertiser, announced his retirement on Thursday in a series of posts on Twitter. "It's with a happy and heavy heart that I've decided to retire from Unilever in April," Weed said on Twitter.

  • Reuters5 days ago

    Unilever Chief Marketing Officer Weed to retire

    The chief marketing officer of Unilever (ULVR.L)(UNc.AS) has decided to retire next year, handing incoming CEO Alan Jope his first big hiring decision. CMO Keith Weed, who oversees the marketing strategy of the world's second-biggest advertiser, announced his retirement on Thursday in a series of posts on Twitter. "It's with a happy and heavy heart that I've decided to retire from Unilever in April," Weed said on Twitter.

  • Unilever's Polman calls for trust in farewell message
    Reuters6 days ago

    Unilever's Polman calls for trust in farewell message

    Unilever boss Paul Polman, quitting months after shareholders scuppered his plan to base company headquarters in the Netherlands, signed off with a typical mixture of advice and philosophy in his last message to investors. The 62-year-old Dutchman, who will be replaced next month by company veteran Alan Jope, is known for his vision of a company with a commitment to sustainability and ethics.

  • Moody's6 days ago

    GlaxoSmithKline Capital Inc. -- Moody's changes GSK's outlook to negative; affirms A2 ratings

    Moody's Investors Service has today changed to negative from stable the outlook of GlaxoSmithKline plc (GSK) and its guaranteed subsidiaries. The change in outlook follows the company's 3 December announcement of its intention to acquire Tesaro for $5.1 billion. At the same time, Moody's has affirmed GSK's A2/(P)A2 long-term and (P)Prime-1 ratings.

  • Reuters7 days ago

    Unilever's incoming CEO sticks with 2020 margin target

    Unilever's (ULVR.L) (UNc.AS) incoming chief executive Alan Jope plans to stick to the 2020 targets set by his predecessor Paul Polman, Jope said on Tuesday, confirming a message of continuity set last week by the company chairman. Following last year's unsolicited $143 billion takeover attempt by Kraft-Heinz (KHC.O), the maker of Dove soap and Hellmann's mayonnaise said it would lift its operating margin to 20 percent by 2020, up from 16.4 percent in 2016. Some observers have worried that the margin target could lead to cost cuts in marketing that could hurt long-term sales growth.

  • Reuters7 days ago

    Unilever's incoming CEO sticks with 2020 margin target

    Unilever's (ULVR.L) (UNc.AS) incoming chief executive Alan Jope plans to stick to the 2020 targets set by his predecessor Paul Polman, Jope said on Tuesday, confirming a message of continuity set last week by the company chairman. Following last year's unsolicited $143 billion (111.54 billion pounds) takeover attempt by Kraft-Heinz (KHC.O), the maker of Dove soap and Hellmann's mayonnaise said it would lift its operating margin to 20 percent by 2020, up from 16.4 percent in 2016. Unilever announced last week that Jope would succeed Polman.

  • Financial Times7 days ago

    [$$] Unilever’s new boss commits to 2020 targets set by predecessor

    Unilever’s incoming chief executive Alan Jope has said he will keep the targets for sales growth and profit margin improvement set by his predecessor, removing a key area of investor concern ahead of a leadership change. Mr Jope relayed the message at an investor day held by Unilever in Mumbai on Tuesday, and a company spokesperson confirmed it to the Financial Times. The 54-year old Unilever lifer, who has been running its beauty and personal care division since 2014, will take over from current chief executive Paul Polman in January.

  • Barrons.com8 days ago

    GlaxoSmithKline Stock Slumps on News of Tesaro Deal

    Glaxo investors aren’t enthused for the biopharma acquisition, which won’t add to the company’s bottom line for years.

  • Unilever swallows GSK's Indian Horlicks business for $3.8 billion
    Reuters8 days ago

    Unilever swallows GSK's Indian Horlicks business for $3.8 billion

    Unilever (ULVR.L) is to buy GlaxoSmithKline's (GSK.L) Horlicks nutrition business for $3.8 billion (2.98 billion pounds), boosting the Anglo-Dutch group's position in India by adding the popular malted drink. The business has annual sales of around 550 million euros, primarily through the malt-based Horlicks and Boost brands.

  • Reuters8 days ago

    Unilever swallows GSK's Indian Horlicks business for $3.8 billion

    Unilever (ULVR.L) is to buy GlaxoSmithKline's (GSK.L) Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group's position in India by adding the popular malted drink. The business has annual sales of around 550 million euros, primarily through the malt-based Horlicks and Boost brands.

  • Associated Press8 days ago

    Unilever agrees to buy GSK business in India

    LONDON (AP) — Unilever has agreed to buy GlaxoSmithKline's health food drinks business in India and Bangladesh, including popular Horlicks brand products, for 3.3 billion euros ($3.8 billion).

  • The Wall Street Journal8 days ago

    [$$] Unilever to Buy Horlicks, One of India's Biggest Brands, From GSK

    PLC as part of a $3.75 billion deal that gives the Anglo-Dutch giant exposure to India’s fast-growing nutritional-drinks market. The acquisition of GSK Consumer Healthcare India will be Unilever’s largest since 2011 when it agreed to buy shampoo maker Alberto Culver for roughly the same price. Unilever—whose portfolio of brands includes Ben & Jerry’s ice cream, Dove soap and Lipton tea—has operated in India through a subsidiary since the 1930s.

  • The Wall Street Journal8 days ago

    [$$] Unilever to Buy GSK's Horlicks Unit

    Unilever has agreed to buy GlaxoSmithKline’s health food drinks portfolio in India--which houses the Horlicks brand--for €3.3 billion.

  • Financial Times8 days ago

    [$$] Unilever agrees €3.3bn deal for GSK’s consumer nutrition business

    With more than 90 per cent of its sales coming from India, the deal also marked a rare chance to acquire a fast-growing product in an emerging market where consumers’ diets are changing as income per head grows. The business has annual sales of roughly €550m, derived largely from the Horlicks and Boost brands.

  • Financial Times11 days ago

    [$$] Unilever veteran Alan Jope takes helm at critical time

    Unilever’s new boss Alan Jope likes a challenge: every year he sets off with a pair of friends on long motorcycle journeys to locales with often punishing terrain, like the Sahara desert, Mongolia and Patagonia. , who delivered years of profitable growth and cut a familiar figure at the United Nations, but Mr Jope must also confront deep changes in the way consumers from Delhi to Dallas eat, drink and buy household products.

  • The Wall Street Journal12 days ago

    [$$] Unilever Names New CEO as Big Brands Regroup, Tackling Consumer Shift

    Unilever PLC, the maker of Hellmann’s mayonnaise and Dove soap, named Alan Jope to replace longtime Chief Executive Paul Polman as it, like the rest of the industry, grapples with a sharp shift in consumer tastes. The appointment of Mr. Jope, a Unilever lifer who currently heads its beauty and personal-care division, comes amid the company’s push under Mr. Polman to bolster that higher-margin business and pivot away from slower-growing food. Unilever and its peers face increased competition from local brands, rising commodity costs, volatile emerging markets and fierce competition from Amazon.com Inc. and discount chains that are increasingly launching own-label products.

  • Unilever CEO set to retire at end of the year
    American City Business Journals12 days ago

    Unilever CEO set to retire at end of the year

    Paul Polman, CEO of consumer products multinational Unilever PLC, is set to retire by the end of 2018. The decision comes amid a tough time for Unilever (NYSE: UL), whose brands include Dove soaps and Lipton tea.

  • TheStreet.com12 days ago

    Unilever Taps In-House Executive as CEO

    , has tapped Alan Jope to become chief executive as current CEO Paul Polman retires. Jope is currently president of the company's beauty and personal care businesses and will take on his new role by January, said Unilever in a press statement on Thursday, Nov. 29. While shares on the London Stock Exchange were up slightly for Unilever, they were down nearly a half percent for the company's American depositary receipts traded in the U.S.

  • CEO Polman to retire from consumer products giant Unilever
    Associated Press12 days ago

    CEO Polman to retire from consumer products giant Unilever

    THE HAGUE, Netherlands (AP) — Paul Polman, CEO of consumer products multinational Unilever, whose brands include Dove soaps and Lipton tea, is retiring at the end of the year, the company said Thursday.

  • Unilever CEO retires after headquarters row, replaced by insider Jope
    Reuters12 days ago

    Unilever CEO retires after headquarters row, replaced by insider Jope

    Unilever's Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes after the Anglo-Dutch group's failed attempt to shift its headquarters. A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company, which makes Dove soap and Ben & Jerry's ice cream, to the Netherlands. Company veteran Jope, 54, is the boss of the beauty and personal care division which is Unilever's largest, accounting for almost half of group annual profits.